Abstract
Low survival rates in combination with significant toxicities caused by current treatment strategies used in oral squamous cell carcinoma (SCC) reinforce the urgent need for more effective therapeutic options. It has been widely accepted that the immune system plays a crucial role in cancer development, as tumor cells evade immunosurveillance by exploiting inhibitory checkpoint pathways t…